Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 5 studies | 43% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 309.00 | 653 / 653 | 5% | 0.10 | 33 / 605 |
| prostate | 99% | 312.24 | 242 / 245 | 2% | 0.05 | 8 / 502 |
| muscle | 100% | 3993.74 | 803 / 803 | 0% | 0 | 0 / 0 |
| heart | 100% | 2637.68 | 859 / 861 | 0% | 0 | 0 / 0 |
| spleen | 100% | 277.51 | 240 / 241 | 0% | 0 | 0 / 0 |
| kidney | 97% | 166.51 | 86 / 89 | 1% | 0.05 | 9 / 901 |
| pancreas | 96% | 152.59 | 314 / 328 | 1% | 0.01 | 1 / 178 |
| adrenal gland | 95% | 145.06 | 246 / 258 | 0% | 0 | 0 / 230 |
| uterus | 92% | 212.91 | 156 / 170 | 2% | 0.12 | 10 / 459 |
| esophagus | 91% | 157.31 | 1322 / 1445 | 1% | 0.01 | 1 / 183 |
| brain | 91% | 180.23 | 2414 / 2642 | 0% | 0.00 | 1 / 705 |
| intestine | 90% | 165.70 | 865 / 966 | 0% | 0.00 | 1 / 527 |
| ovary | 89% | 226.31 | 161 / 180 | 0% | 0 | 0 / 430 |
| stomach | 86% | 126.32 | 309 / 359 | 0% | 0.01 | 1 / 286 |
| liver | 79% | 97.82 | 179 / 226 | 0% | 0 | 0 / 406 |
| breast | 67% | 75.24 | 308 / 459 | 1% | 0.05 | 10 / 1118 |
| skin | 65% | 77.37 | 1184 / 1809 | 0% | 0 | 0 / 472 |
| lung | 63% | 84.82 | 362 / 578 | 1% | 0.02 | 12 / 1155 |
| bladder | 62% | 90.90 | 13 / 21 | 1% | 0.01 | 3 / 504 |
| adipose | 61% | 60.31 | 732 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 40% | 51.94 | 534 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 33% | 58.35 | 305 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.02 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0016529 | Cellular component | sarcoplasmic reticulum |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FSD2 |
| Protein name | FSD2 protein Fibronectin type III and SPRY domain containing 2 Fibronectin type III and SPRY domain-containing protein 2 (SPRY domain-containing protein 1) |
| Synonyms | SPRYD1 |
| Description | |
| Accessions | A1L4K1 ENST00000541889.1 [A1L4K1-2] ENST00000561368.1 H0YLA8 ENST00000334574.12 [A1L4K1-1] B7ZM05 |